Skip to main content
Clinical Trials/DRKS00000625
DRKS00000625
Completed
Not Applicable

Prospective observational study to assess the efficacy and tolerability of Eptadone®, in heroin addicted patients undergoing a methadone maintenance treatment. - Metho.de

. Molteni & C. dei F.lli Alitti – Soc. di Esercizio S.p.A.0 sites516 target enrollmentDecember 28, 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
F10-F19
Sponsor
. Molteni & C. dei F.lli Alitti – Soc. di Esercizio S.p.A.
Enrollment
516
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 28, 2010
End Date
February 24, 2013
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
. Molteni & C. dei F.lli Alitti – Soc. di Esercizio S.p.A.

Eligibility Criteria

Inclusion Criteria

  • (i) Both sexes;
  • (ii) Over 18 years of age;
  • (iii) Patients with a diagnosis of heroin addiction, according to ICD\-10
  • (iv) Patients who starts or have started a maintenance treatment” with Eptadone®
  • (v) Accession to the observational study by informed consent.

Exclusion Criteria

  • Patients with the following criteria will not be observed:
  • a) Inability to follow the observation, and to understand study procedures and follow them;
  • b) Diagnosis of:
  • (i) Decompensated psychotic disorders,
  • (ii) Epileptic attacks, not related with drug abuse,
  • (iii) Severe\-acute or severe\-chronic somatic diseases (like AIDS, Tubercolosis, acute hepatitis, Sepsis ecc.), whereas chronical HCV is not an exclusion criteria.

Outcomes

Primary Outcomes

Not specified

Similar Trials